Invasive Fungal Infections After Liver Transplantation: A Retrospective Matched Controlled Risk Analysis

06 August 2021: Original Paper

Halil-Ibrahim Karadag ^1ACDEF , Oya Andacoglu ^2CDEF , Marios Papadakis ^3BCEF , Andreas Paul ^1ACD , Arzu Oezcelik ^1ACDE* , Eugen Malamutmann ^1AD

DOI: 10.12659/AOT.930117

Ann Transplant 2021; 26:e930117

Table 3 Comparison of the donor data.

	AGn=14	CGn=19	Controln=99	p-value
Age (median IQR)	48.1 (17.9)	51.4 (20.3)	56.4 (16.27)	0.175
Sex (Male/Female)	6/8	8/11	38/61	0.919
BMI (kg/m) (median IQR)	25 (22.6–26.4)	26.7 (4.7–27.8)	26.0 (23–28)	0.475
LOS-ICU (median IQR)	6 (2–7)	3 (2–4)	4 (2–7)	0.387
AST (U/l) (median IQR)	77 (38–133)	49 (30–117)	53 (27–108)	0.598
ALT (U/l) (median IQR)	57 (30–94)	37 (21–60)	30 (17–74)	0.135
γGT (U/l) (median IQR)	52 (24–167)	54 (23–118)	34 (16–101)	0.339
Bilirubin(mg/dl) (median IQR)	0.5 (0.3/0.85)	0.4 (0.22/0.82)	0.5 (0.3/0.8)	0.888
Fungal contamination of preservation fluid n (%)	1 (7.0%)	4 (21.0%)	2 (2%)
ET-DRI (median IQR)	1.6 (1.4–2.1)	1.7 (1.5–2.0)	1.9 (1.7–2.2)	0.053
AG – Aspergillus-group; CG – Candida-group; BMI – body mass index; ICU – Intensive Care Unit; AST – aspartate-aminotransferase; ALT – alanine-aminotransferase, γGT – glutamat-pyruvat-transaminase; ET-DRI – Eurotransplant Donor-Risk-Index; IQR – interquartile range.